# Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

> **NCT01318941** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 30490 (actual)

## Conditions studied

- Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
- Wet Age Related Macular Degeneration
- Diabetic Macular Edema
- Retinal Vein Occlusion

## Interventions

- **DRUG:** Ranibizumab
- **OTHER:** Ranibizumab

## Key facts

- **NCT ID:** NCT01318941
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 30490 (ACTUAL)
- **Last updated:** 2016-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01318941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01318941, "Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01318941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*